Jerrold D. Dotson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jerrold D. Dotson
Earlier roles on record: CFO at Vistagen Therapeutics, Inc. (VTGN) until August 21, 2023. Vistagen Therapeutics, Inc. reported in an 8-K filed August 22, 2023 that Jerrold D. Dotson retired as Chief Financial Officer, effective August 21, 2023.
“Ms. Anderson replaces Mr. Jerrold Dotson upon his retirement, effective August 21, 2023, as previously reported.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-08-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.